Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8764
Revised: February 14, 2014
Accepted: April 15, 2014
Published online: July 21, 2014
Processing time: 266 Days and 16.3 Hours
Extraintestinal manifestations occur in about one-third of patients living with inflammatory bowel disease (IBD) and may precede the onset of gastrointestinal symptoms by many years. Neurologic disorders associated with IBD are not frequent, being reported in 3% of patients, but they often represent an important cause of morbidity and a relevant diagnostic issue. In addition, the increasing use of immunosuppressant and biological therapies for IBD may also play a pivotal role in the development of neurological disorders of different type and pathogenesis. Hence, we provide a complete and profound review of the main features of neurological complications associated with IBD, with particular reference to those related to drugs and with a specific focus on their clinical presentation and possible pathophysiological mechanisms.
Core tip: Extraintestinal manifestations occur in about one-third of patients with inflammatory bowel disease (IBD) and may precede the onset of gastrointestinal symptoms by many years. Neurological disorders are uncommon in IBD but they can represent an important cause of morbidity and relevant diagnostic issue. Furthermore, the use of immunosuppressant and biological therapies for IBD may also play a pivotal role in the development of neurological disorders. Hence, we review the main features of neurological complications associated with IBD, with particular reference to those related to drugs, thereby focusing on their clinical presentation and possible pathophysiological mechanisms.